id stringlengths 11 11 | tags stringlengths 10 513 | text stringlengths 3 1.35k | entities dict | ner_tags listlengths 1 222 | tokens listlengths 1 222 | __index_level_0__ int64 0 7.36k |
|---|---|---|---|---|---|---|
NCT02075671 | ,33:55:treatment,46:55:treatment,60:67:chronic_disease,69:82:treatment,84:104:treatment,106:118:treatment,120:132:treatment | History of failing at least one conventional treatment for rosacea (metronidazole, sodium sulfacetamide, tetracycline, azelaic acid) or not interested in continuous treatment with these agents | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "rosacea",
"treatment": "azelaic acid"
} | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] | [
"History",
"of",
"failing",
"at",
"least",
"one",
"conventional",
"treatment",
"for",
"rosacea",
"(metronidazole,",
"sodium",
"sulfacetamide,",
"tetracycline,",
"azelaic",
"acid)",
"or",
"not",
"interested",
"in",
"continuous",
"treatment",
"with",
"these",
"agents"
] | 6,797 |
NCT02346526 | 10:31:treatment, | Received previous radiotherapy to approximately >25% of bone marrow | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "previous radiotherapy"
} | [
0,
0,
1,
0,
0,
0,
0,
0,
0
] | [
"Received",
"previous",
"radiotherapy",
"to",
"approximately",
">25%",
"of",
"bone",
"marrow"
] | 4,563 |
NCT02977468 | ,,,176:186:treatment | Female subjects of childbearing potential must be willing to use an adequate method of contraception for the course of the study through 120 days after the last dose of study medication | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "medication"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Female",
"subjects",
"of",
"childbearing",
"potential",
"must",
"be",
"willing",
"to",
"use",
"an",
"adequate",
"method",
"of",
"contraception",
"for",
"the",
"course",
"of",
"the",
"study",
"through",
"120",
"days",
"after",
"the",
"last",
"dose",
"of",
"s... | 619 |
NCT01925131 | 1:22:treatment, | Monoclonal antibodies must not have been received for 1 week prior to registration | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "Monoclonal antibodies"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Monoclonal",
"antibodies",
"must",
"not",
"have",
"been",
"received",
"for",
"1",
"week",
"prior",
"to",
"registration"
] | 3,297 |
NCT02070549 | ,44:68:chronic_disease, | History or evidence of current >= class II congestive heart failure as defined by the New York Heart Association (NYHA) functional classification system | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "congestive heart failure",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] | [
"History",
"or",
"evidence",
"of",
"current",
">=",
"class",
"II",
"congestive",
"heart",
"failure",
"as",
"defined",
"by",
"the",
"New",
"York",
"Heart",
"Association",
"(NYHA)",
"functional",
"classification",
"system"
] | 812 |
NCT02981173 | 10:26:chronic_disease | Episodic cluster headache with periods that are predictable | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "cluster headache",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Episodic",
"cluster",
"headache",
"with",
"periods",
"that",
"are",
"predictable"
] | 3,747 |
NCT02451215 | 1:11:cancer | Ependymoma | {
"allergy_name": null,
"cancer": "Ependymoma",
"chronic_disease": null,
"treatment": null
} | [
3
] | [
"Ependymoma"
] | 4,409 |
NCT01464034 | 17:35:treatment,37:44:treatment,59:76:treatment,,140:148:treatment,213:236:chronic_disease | Exposure to any prior chemotherapy, steroid use, or other myeloma treatment within 14 days prior to first dose. Pts currently on long term steroids do not require any washout period. in addition, steroid use for spinal cord compression is permitted and does not require a washout period | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "spinal cord compression",
"treatment": "steroids"
} | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
3,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Exposure",
"to",
"any",
"prior",
"chemotherapy,",
"steroid",
"use,",
"or",
"other",
"myeloma",
"treatment",
"within",
"14",
"days",
"prior",
"to",
"first",
"dose.",
"Pts",
"currently",
"on",
"long",
"term",
"steroids",
"do",
"not",
"require",
"any",
"washout"... | 7,205 |
NCT02577406 | ,,,,,389:398:treatment,436:446:treatment,484:495:treatment | Male subjects must agree to practice true abstinence from sexual intercourse or to the use of highly effective contraceptive methods (as described above) with non-pregnant female partners of childbearing potential at screening and throughout the course of the study, and should avoid conception with their partners durin... | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "azacitidine"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0... | [
"Male",
"subjects",
"must",
"agree",
"to",
"practice",
"true",
"abstinence",
"from",
"sexual",
"intercourse",
"or",
"to",
"the",
"use",
"of",
"highly",
"effective",
"contraceptive",
"methods",
"(as",
"described",
"above)",
"with",
"non-pregnant",
"female",
"partne... | 5,933 |
NCT01956084 | 7:10:chronic_disease | Donor HIV negative | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "HIV",
"treatment": null
} | [
0,
2,
0
] | [
"Donor",
"HIV",
"negative"
] | 186 |
NCT02204098 | ,,,125:138:cancer,197:204:treatment,230:235:cancer | Clinical T2-T4c, any N, M0 invasive ER+ (Allred Score of 6-8) and HER2- (0 or 1+ by IHC or FISH negative for amplification) breast cancer by AJCC 7th edition clinical staging, with the goal being surgery to completely excise the tumor in the breast and the lymph node | {
"allergy_name": null,
"cancer": "tumor",
"chronic_disease": null,
"treatment": "surgery"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0
] | [
"Clinical",
"T2-T4c,",
"any",
"N,",
"M0",
"invasive",
"ER+",
"(Allred",
"Score",
"of",
"6-8)",
"and",
"HER2-",
"(0",
"or",
"1+",
"by",
"IHC",
"or",
"FISH",
"negative",
"for",
"amplification)",
"breast",
"cancer",
"by",
"AJCC",
"7th",
"edition",
"clinical",
... | 6,626 |
NCT02563574 | 1:26:chronic_disease | Major psychiatric illness | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Major psychiatric illness",
"treatment": null
} | [
0,
2,
2
] | [
"Major",
"psychiatric",
"illness"
] | 2,525 |
NCT03042689 | 14:55:cancer | Diagnosis of relapsed/refractory advanced malignancies | {
"allergy_name": null,
"cancer": "relapsed/refractory advanced malignancies",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
3
] | [
"Diagnosis",
"of",
"relapsed/refractory",
"advanced",
"malignancies"
] | 3,668 |
NCT01976169 | 10:13:chronic_disease | Baseline HIV screening | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "HIV",
"treatment": null
} | [
0,
2,
0
] | [
"Baseline",
"HIV",
"screening"
] | 184 |
NCT02555280 | 1:22:chronic_disease,, | Mild lumbar scoliosis (Cobb angle up to 25º) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Mild lumbar scoliosis",
"treatment": null
} | [
0,
0,
2,
0,
0,
0,
0,
0
] | [
"Mild",
"lumbar",
"scoliosis",
"(Cobb",
"angle",
"up",
"to",
"25º)"
] | 4,190 |
NCT02304458 | 28:61:treatment | Patients who have received prior solid organ transplantation | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "prior solid organ transplantation"
} | [
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Patients",
"who",
"have",
"received",
"prior",
"solid",
"organ",
"transplantation"
] | 2,882 |
NCT02583893 | 1:11:treatment,18:25:treatment,43:54:treatment,56:68:treatment,70:82:treatment,84:96:treatment,102:114:treatment, | Tacrolimus (e.g. Prograf) Subjects taking fluconozole, voriconizole, itraconazole, posaconazole, and ketokonazole within 72 hours of study drug starting | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "ketokonazole"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] | [
"Tacrolimus",
"(e.g.",
"Prograf)",
"Subjects",
"taking",
"fluconozole,",
"voriconizole,",
"itraconazole,",
"posaconazole,",
"and",
"ketokonazole",
"within",
"72",
"hours",
"of",
"study",
"drug",
"starting"
] | 5,909 |
NCT02981069 | 30:64:chronic_disease,,,,,,, | Individuals with evidence of proliferative diabetic retinopathy, plasma creatinine >1.4 females or >1.5 males, or 24-hour urine albumin excretion > 300 mg will be excluded | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "proliferative diabetic retinopathy",
"treatment": null
} | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Individuals",
"with",
"evidence",
"of",
"proliferative",
"diabetic",
"retinopathy,",
"plasma",
"creatinine",
">1.4",
"females",
"or",
">1.5",
"males,",
"or",
"24-hour",
"urine",
"albumin",
"excretion",
">",
"300",
"mg",
"will",
"be",
"excluded"
] | 3,080 |
NCT02473250 | 1:14:chronic_disease | renal failure | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "renal failure",
"treatment": null
} | [
0,
0
] | [
"renal",
"failure"
] | 1,858 |
NCT03149783 | 39:50:allergy_name | Patients with a documented allergy to ropivacaine | {
"allergy_name": "ropivacaine",
"cancer": null,
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
4
] | [
"Patients",
"with",
"a",
"documented",
"allergy",
"to",
"ropivacaine"
] | 3,527 |
NCT02554253 | 15:32:chronic_disease,, | pre-operative renal dysfunction including a baseline creatinine equal to or greater than 1.5 mg/dL or requiring dialysis | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "renal dysfunction",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"pre-operative",
"renal",
"dysfunction",
"including",
"a",
"baseline",
"creatinine",
"equal",
"to",
"or",
"greater",
"than",
"1.5",
"mg/dL",
"or",
"requiring",
"dialysis"
] | 2,082 |
NCT00924027 | 1:12:cancer | Lung cancer | {
"allergy_name": null,
"cancer": "Lung cancer",
"chronic_disease": null,
"treatment": null
} | [
0,
3
] | [
"Lung",
"cancer"
] | 2,997 |
NCT02081404 | 12:31:chronic_disease | History of Barrett's esophagus | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Barrett's esophagus",
"treatment": null
} | [
0,
0,
0,
0
] | [
"History",
"of",
"Barrett's",
"esophagus"
] | 2,561 |
NCT02925923 | 1:10:treatment | Lopinavir | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "Lopinavir"
} | [
1
] | [
"Lopinavir"
] | 3,806 |
NCT02105545 | 29:62:chronic_disease | Patients may have existing, non-oncological genetic disorders | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "non-oncological genetic disorders",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0
] | [
"Patients",
"may",
"have",
"existing,",
"non-oncological",
"genetic",
"disorders"
] | 4,865 |
NCT01760655 | 1:4:cancer | ALL with any morphological evidence of disease will not be eligible | {
"allergy_name": null,
"cancer": "ALL",
"chronic_disease": null,
"treatment": null
} | [
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"ALL",
"with",
"any",
"morphological",
"evidence",
"of",
"disease",
"will",
"not",
"be",
"eligible"
] | 2,499 |
NCT02338232 | 17:31:treatment,33:54:treatment,59:73:treatment,88:115:treatment,200:219:treatment | Subjects taking ACE inhibitors, potassium supplements, or spironolactone (or any other potassium-sparing diuretics) who cannot discontinue use prior to initiation of study treatment OR who require a high-potassium diet | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "high-potassium diet"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] | [
"Subjects",
"taking",
"ACE",
"inhibitors,",
"potassium",
"supplements,",
"or",
"spironolactone",
"(or",
"any",
"other",
"potassium-sparing",
"diuretics)",
"who",
"cannot",
"discontinue",
"use",
"prior",
"to",
"initiation",
"of",
"study",
"treatment",
"OR",
"who",
"r... | 6,459 |
NCT02982226 | ,38:85:treatment,93:114:treatment,116:121:treatment,123:129:treatment,131:140:treatment,142:158:treatment | Completed a minimum of two months of conservative, non-injection treatment/therapies (i.e., activity modification, icing, NSAIDs, orthotics, physical therapy, etc.) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "physical therapy"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Completed",
"a",
"minimum",
"of",
"two",
"months",
"of",
"conservative,",
"non-injection",
"treatment/therapies",
"(i.e.,",
"activity",
"modification,",
"icing,",
"NSAIDs,",
"orthotics,",
"physical",
"therapy,",
"etc.)"
] | 5,686 |
NCT02207439 | ,,,61:83:chronic_disease | Weight loss of > 10% over the past 6 months which is due to tumor wasting syndrome | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "tumor wasting syndrome",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
2
] | [
"Weight",
"loss",
"of",
">",
"10%",
"over",
"the",
"past",
"6",
"months",
"which",
"is",
"due",
"to",
"tumor",
"wasting",
"syndrome"
] | 4,731 |
NCT02809677 | 9:19:chronic_disease | current depression secondary to substances or general medical condition | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "depression",
"treatment": null
} | [
0,
2,
0,
0,
0,
0,
0,
0,
0
] | [
"current",
"depression",
"secondary",
"to",
"substances",
"or",
"general",
"medical",
"condition"
] | 1,482 |
NCT01676259 | 1:18:chronic_disease | hepatitis B virus | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "hepatitis B virus",
"treatment": null
} | [
2,
0,
0
] | [
"hepatitis",
"B",
"virus"
] | 3,321 |
NCT02780401 | 1:16:chronic_disease, | Unstable angina within 4 months prior to enrollment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Unstable angina",
"treatment": null
} | [
0,
2,
0,
0,
0,
0,
0,
0
] | [
"Unstable",
"angina",
"within",
"4",
"months",
"prior",
"to",
"enrollment"
] | 1,789 |
NCT01505062 | 29:39:allergy_name | Contraindications to use of anesthesia (local or general, as appropriate) | {
"allergy_name": "anesthesia",
"cancer": null,
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
4,
0,
0,
0,
0,
0
] | [
"Contraindications",
"to",
"use",
"of",
"anesthesia",
"(local",
"or",
"general,",
"as",
"appropriate)"
] | 1,954 |
NCT02411656 | 24:58:chronic_disease | Has a known history of human immunodeficiency virus (HIV) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "human immunodeficiency virus (HIV)",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
2,
0,
0
] | [
"Has",
"a",
"known",
"history",
"of",
"human",
"immunodeficiency",
"virus",
"(HIV)"
] | 1,378 |
NCT02400463 | ,,,99:108:treatment | all females of child-bearing potential must have a negative serum pregnancy test within 7 days of treatment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"all",
"females",
"of",
"child-bearing",
"potential",
"must",
"have",
"a",
"negative",
"serum",
"pregnancy",
"test",
"within",
"7",
"days",
"of",
"treatment"
] | 1,058 |
NCT01799538 | 1:21:chronic_disease | Cognitive Impairment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Cognitive Impairment",
"treatment": null
} | [
0,
0
] | [
"Cognitive",
"Impairment"
] | 5,090 |
NCT02780401 | ,35:62:treatment,64:76:treatment,78:97:treatment,111:127:treatment | Patients must be at least 28 days post cytotoxic chemotherapy, radiotherapy, monoclonal antibody and/or other biologic therapy, prior to enrollment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "biologic therapy"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Patients",
"must",
"be",
"at",
"least",
"28",
"days",
"post",
"cytotoxic",
"chemotherapy,",
"radiotherapy,",
"monoclonal",
"antibody",
"and/or",
"other",
"biologic",
"therapy,",
"prior",
"to",
"enrollment"
] | 5,800 |
NCT02394028 | 1:49:treatment,54:56:chronic_disease,86:95:chronic_disease | Treatment with antibiotics as adjunctive therapy for CD in the absence of documented infection | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "infection",
"treatment": "Treatment with antibiotics as adjunctive therapy"
} | [
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
2
] | [
"Treatment",
"with",
"antibiotics",
"as",
"adjunctive",
"therapy",
"for",
"CD",
"in",
"the",
"absence",
"of",
"documented",
"infection"
] | 6,358 |
NCT02452697 | 15:35:chronic_disease,55:88:treatment,92:131:treatment | Patients with hematologic diseases who have undergone T-cell depleted reduced intensity or non-ablative allogeneic transplantation, using a 7-8/8 HLA-matched related or unrelated donor or 4-6/8 HLA-matched related donor | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "hematologic diseases",
"treatment": "non-ablative allogeneic transplantation"
} | [
0,
0,
2,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Patients",
"with",
"hematologic",
"diseases",
"who",
"have",
"undergone",
"T-cell",
"depleted",
"reduced",
"intensity",
"or",
"non-ablative",
"allogeneic",
"transplantation,",
"using",
"a",
"7-8/8",
"HLA-matched",
"related",
"or",
"unrelated",
"donor",
"or",
"4-6/8",... | 6,250 |
NCT02133872 | ,49:65:treatment | More than one in-patient hospitalization for an antihypertensive crisis within the year | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "antihypertensive"
} | [
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0
] | [
"More",
"than",
"one",
"in-patient",
"hospitalization",
"for",
"an",
"antihypertensive",
"crisis",
"within",
"the",
"year"
] | 4,828 |
NCT02145351 | 1:16:treatment,21:23:chronic_disease,29:54:treatment,58:72:treatment | Acute treatment for HF with intravenous loop diuretic or hemofiltration | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "HF",
"treatment": "hemofiltration"
} | [
0,
1,
0,
2,
0,
0,
0,
0,
0,
1
] | [
"Acute",
"treatment",
"for",
"HF",
"with",
"intravenous",
"loop",
"diuretic",
"or",
"hemofiltration"
] | 6,704 |
NCT01045148 | 7:14:chronic_disease,18:37:chronic_disease,104:113:treatment | Major medical or psychiatric illness, which in the investigator's opinion, would prevent completion of treatment and would interfere with follow-up | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "psychiatric illness",
"treatment": "treatment"
} | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] | [
"Major",
"medical",
"or",
"psychiatric",
"illness,",
"which",
"in",
"the",
"investigator's",
"opinion,",
"would",
"prevent",
"completion",
"of",
"treatment",
"and",
"would",
"interfere",
"with",
"follow-up"
] | 5,399 |
NCT02311621 | 1:20:cancer | Skull based disease with soft tissue extension | {
"allergy_name": null,
"cancer": "Skull based disease",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0
] | [
"Skull",
"based",
"disease",
"with",
"soft",
"tissue",
"extension"
] | 4,622 |
NCT02466750 | ,87:94:treatment | Agree to defer blood, bone marrow, and organ donation for 1 year after receipt of the vaccine | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "vaccine"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4
] | [
"Agree",
"to",
"defer",
"blood,",
"bone",
"marrow,",
"and",
"organ",
"donation",
"for",
"1",
"year",
"after",
"receipt",
"of",
"the",
"vaccine"
] | 2,011 |
NCT02624258 | 14:30:chronic_disease | Uncontrolled active infection | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "active infection",
"treatment": null
} | [
0,
0,
2
] | [
"Uncontrolled",
"active",
"infection"
] | 265 |
NCT02833207 | 1:47:treatment | non-steroidal anti-inflammatory drugs (NSAIDs) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "non-steroidal anti-inflammatory drugs (NSAIDs)"
} | [
0,
1,
0,
0
] | [
"non-steroidal",
"anti-inflammatory",
"drugs",
"(NSAIDs)"
] | 3,059 |
NCT02535312 | 1:25:treatment | anti-seizure medications are eligible to participate | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "anti-seizure medications"
} | [
0,
1,
0,
0,
0,
0
] | [
"anti-seizure",
"medications",
"are",
"eligible",
"to",
"participate"
] | 4,230 |
NCT02709980 | 1:26:chronic_disease | major depressive disorder | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "major depressive disorder",
"treatment": null
} | [
0,
0,
2
] | [
"major",
"depressive",
"disorder"
] | 2,111 |
NCT02445768 | 1:12:chronic_disease,16:32:chronic_disease,48:51:treatment | subcortical or cortical infarct confirmed with MRI | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "cortical infarct",
"treatment": "MRI"
} | [
0,
0,
0,
0,
0,
0,
4
] | [
"subcortical",
"or",
"cortical",
"infarct",
"confirmed",
"with",
"MRI"
] | 6,273 |
NCT01220583 | ,,,123:132:treatment, | Women of childbearing potential and male participants who are sexually active must practice adequate contraception during treatment and for 6 weeks following treatment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1
] | [
"Women",
"of",
"childbearing",
"potential",
"and",
"male",
"participants",
"who",
"are",
"sexually",
"active",
"must",
"practice",
"adequate",
"contraception",
"during",
"treatment",
"and",
"for",
"6",
"weeks",
"following",
"treatment"
] | 1,236 |
NCT02624258 | 69:88:allergy_name,90:94:allergy_name,100:110:allergy_name | History of allergy or hypersensitivity to study product excipients (human serum albumin, DMSO, and Dextran 40) | {
"allergy_name": "Dextran 40",
"cancer": null,
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] | [
"History",
"of",
"allergy",
"or",
"hypersensitivity",
"to",
"study",
"product",
"excipients",
"(human",
"serum",
"albumin,",
"DMSO,",
"and",
"Dextran",
"40)"
] | 5,865 |
NCT02135588 | ,22:41:treatment | At least 7 days from prior major surgery | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "prior major surgery"
} | [
0,
0,
0,
0,
0,
0,
0,
1
] | [
"At",
"least",
"7",
"days",
"from",
"prior",
"major",
"surgery"
] | 3,313 |
NCT02579967 | 15:49:chronic_disease,53:83:chronic_disease,109:117:cancer,165:189:chronic_disease | Patients with hemophagocytic lymphohistiocytosis or macrophage activation syndrome related to an underlying lymphoma with no other clinical history suggestive of a primary immunodeficiency | {
"allergy_name": null,
"cancer": "lymphoma",
"chronic_disease": "primary immunodeficiency",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] | [
"Patients",
"with",
"hemophagocytic",
"lymphohistiocytosis",
"or",
"macrophage",
"activation",
"syndrome",
"related",
"to",
"an",
"underlying",
"lymphoma",
"with",
"no",
"other",
"clinical",
"history",
"suggestive",
"of",
"a",
"primary",
"immunodeficiency"
] | 5,926 |
NCT01908777 | 24:34:treatment | progressive disease at transplant work-up | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "transplant"
} | [
0,
0,
0,
1,
0
] | [
"progressive",
"disease",
"at",
"transplant",
"work-up"
] | 1,594 |
NCT00862433 | 7:19:chronic_disease | Known coagulopathy | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "coagulopathy",
"treatment": null
} | [
0,
2
] | [
"Known",
"coagulopathy"
] | 1,642 |
NCT02392572 | 51:64:treatment, | Persistent clinically significant toxicities from prior therapy must not be greater than grade 1 | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "prior therapy"
} | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] | [
"Persistent",
"clinically",
"significant",
"toxicities",
"from",
"prior",
"therapy",
"must",
"not",
"be",
"greater",
"than",
"grade",
"1"
] | 19 |
NCT02382419 | ,14:21:treatment,,111:126:treatment,111:114:chronic_disease,115:126:treatment,,342:352:treatment,,,478:486:treatment,, | Women in the vaccine-eligible age range cannot have received vaccine prior to enrollment, but will be offered HPV vaccination at the end of the study; in brief, we are interested in the efficacy of intervention in preventing HPV in the absence of HPV vaccination, since most women worldwide who might utilize interventio... | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "HPV",
"treatment": "Vaccines"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... | [
"Women",
"in",
"the",
"vaccine-eligible",
"age",
"range",
"cannot",
"have",
"received",
"vaccine",
"prior",
"to",
"enrollment,",
"but",
"will",
"be",
"offered",
"HPV",
"vaccination",
"at",
"the",
"end",
"of",
"the",
"study;",
"in",
"brief,",
"we",
"are",
"in... | 6,391 |
NCT01684904 | 15:44:cancer | Patients with cervical esophageal carcinoma | {
"allergy_name": null,
"cancer": "cervical esophageal carcinoma",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
3,
3
] | [
"Patients",
"with",
"cervical",
"esophageal",
"carcinoma"
] | 3,155 |
NCT02408861 | 1:4:chronic_disease,, | HIV viral load should be well suppressed, defined as below the limit of detection of the local assay or below 75 copies/mL by Food and Drug Administration (FDA)-approved assays, within 4 weeks prior to registration | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "HIV",
"treatment": null
} | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"HIV",
"viral",
"load",
"should",
"be",
"well",
"suppressed,",
"defined",
"as",
"below",
"the",
"limit",
"of",
"detection",
"of",
"the",
"local",
"assay",
"or",
"below",
"75",
"copies/mL",
"by",
"Food",
"and",
"Drug",
"Administration",
"(FDA)-approved",
"assay... | 124 |
NCT01436968 | 1:14:chronic_disease,32:41:chronic_disease,52:61:chronic_disease | Liver disease, including known cirrhosis or active hepatitis | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "hepatitis",
"treatment": null
} | [
0,
0,
0,
0,
2,
0,
0,
2
] | [
"Liver",
"disease,",
"including",
"known",
"cirrhosis",
"or",
"active",
"hepatitis"
] | 7,210 |
NCT02181478 | 1:19:treatment,24:47:cancer,51:88:cancer | Concurrent therapy for extramedullary leukemia or central nervous system (CNS) lymphoma | {
"allergy_name": null,
"cancer": "central nervous system (CNS) lymphoma",
"chronic_disease": null,
"treatment": "Concurrent therapy"
} | [
0,
1,
0,
0,
3,
0,
0,
0,
0,
0,
3
] | [
"Concurrent",
"therapy",
"for",
"extramedullary",
"leukemia",
"or",
"central",
"nervous",
"system",
"(CNS)",
"lymphoma"
] | 6,658 |
NCT02495168 | 18:43:treatment, | plans to receive investigational treatment within 30 days after the study is completed | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "investigational treatment"
} | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"plans",
"to",
"receive",
"investigational",
"treatment",
"within",
"30",
"days",
"after",
"the",
"study",
"is",
"completed"
] | 3,271 |
NCT02593123 | 1:35:cancer | Chronic myelogenous leukemia (CML) | {
"allergy_name": null,
"cancer": "Chronic myelogenous leukemia (CML)",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
3,
0
] | [
"Chronic",
"myelogenous",
"leukemia",
"(CML)"
] | 2,859 |
NCT02053909 | ,,53:74:treatment | Serum creatinine >1.8 mg/dL (need for contrast with CT coronary angiogram) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "CT coronary angiogram"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] | [
"Serum",
"creatinine",
">1.8",
"mg/dL",
"(need",
"for",
"contrast",
"with",
"CT",
"coronary",
"angiogram)"
] | 4,918 |
NCT01754298 | 1:13:treatment | chemotherapy treatment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "chemotherapy"
} | [
1,
1
] | [
"chemotherapy",
"treatment"
] | 370 |
NCT02664909 | 12:30:chronic_disease | history of pulmonary embolism | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "pulmonary embolism",
"treatment": null
} | [
0,
0,
2,
0
] | [
"history",
"of",
"pulmonary",
"embolism"
] | 2,342 |
NCT02962557 | 27:50:treatment,52:65:treatment,67:84:treatment,90:103:treatment | Sample procedures include major extremity surgery, spine surgery, abdominal surgery, and chest surgery that require a post operative in patient hospital stay | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "chest surgery"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Sample",
"procedures",
"include",
"major",
"extremity",
"surgery,",
"spine",
"surgery,",
"abdominal",
"surgery,",
"and",
"chest",
"surgery",
"that",
"require",
"a",
"post",
"operative",
"in",
"patient",
"hospital",
"stay"
] | 5,696 |
NCT02393794 | 1:14:cancer,30:47:chronic_disease,64:80:treatment | Breast cancer that is either stage III disease not amenable to curative therapy or stage IV | {
"allergy_name": null,
"cancer": "Breast cancer",
"chronic_disease": "stage III disease",
"treatment": "curative therapy"
} | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] | [
"Breast",
"cancer",
"that",
"is",
"either",
"stage",
"III",
"disease",
"not",
"amenable",
"to",
"curative",
"therapy",
"or",
"stage",
"IV"
] | 6,361 |
NCT02553941 | 1:11:cancer,25:40:treatment,,122:132:treatment | Malignancy treated with curative intent and with no known active disease present for >= 1 years before the first dose of study drug and felt to be at low risk for recurrence by treating physician | {
"allergy_name": null,
"cancer": "Malignancy",
"chronic_disease": null,
"treatment": "study drug"
} | [
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Malignancy",
"treated",
"with",
"curative",
"intent",
"and",
"with",
"no",
"known",
"active",
"disease",
"present",
"for",
">=",
"1",
"years",
"before",
"the",
"first",
"dose",
"of",
"study",
"drug",
"and",
"felt",
"to",
"be",
"at",
"low",
"risk",
"for",
... | 5,998 |
NCT02488057 | 1:9:chronic_disease | diabetic | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "diabetic",
"treatment": null
} | [
2
] | [
"diabetic"
] | 2,222 |
NCT02555189 | 19:36:treatment,38:50:treatment,52:63:treatment | Administration of antifungal agents (itraconazole, fluconazole, etc) within 4 weeks of enrollment or unrecovered AEs due to agents administered more than 4 weeks of enrollment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "fluconazole"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Administration",
"of",
"antifungal",
"agents",
"(itraconazole,",
"fluconazole,",
"etc)",
"within",
"4",
"weeks",
"of",
"enrollment",
"or",
"unrecovered",
"AEs",
"due",
"to",
"agents",
"administered",
"more",
"than",
"4",
"weeks",
"of",
"enrollment"
] | 5,989 |
NCT03158519 | 19:34:treatment,66:75:treatment,79:98:treatment,111:118:treatment,120:129:treatment,138:150:treatment, | Completion of all primary therapy (with the exception of ongoing endocrine or trastuzumab therapy), including surgery, radiation, and/or chemotherapy greater than 4 weeks prior to study enrollment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "chemotherapy"
} | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Completion",
"of",
"all",
"primary",
"therapy",
"(with",
"the",
"exception",
"of",
"ongoing",
"endocrine",
"or",
"trastuzumab",
"therapy),",
"including",
"surgery,",
"radiation,",
"and/or",
"chemotherapy",
"greater",
"than",
"4",
"weeks",
"prior",
"to",
"study",
... | 5,523 |
NCT01660607 | 1:4:chronic_disease | HIV ab | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "HIV",
"treatment": null
} | [
2,
0
] | [
"HIV",
"ab"
] | 201 |
NCT03005951 | 1:20:chronic_disease | Developmental delay | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Developmental delay",
"treatment": null
} | [
0,
0
] | [
"Developmental",
"delay"
] | 3,723 |
NCT01572480 | ,59:62:cancer,,, | Progressive increase in M protein level (evolving type of SMM; increase in serum M protein by greater than or equal to 25% on 2 successive evaluations within a 6-month period) | {
"allergy_name": null,
"cancer": "SMM",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Progressive",
"increase",
"in",
"M",
"protein",
"level",
"(evolving",
"type",
"of",
"SMM;",
"increase",
"in",
"serum",
"M",
"protein",
"by",
"greater",
"than",
"or",
"equal",
"to",
"25%",
"on",
"2",
"successive",
"evaluations",
"within",
"a",
"6-month",
"pe... | 2,965 |
NCT01312857 | 18:28:cancer | History of other malignancy | {
"allergy_name": null,
"cancer": "malignancy",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
2
] | [
"History",
"of",
"other",
"malignancy"
] | 555 |
NCT01895777 | 24:43:chronic_disease | including known active hepatitis A, B or C | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "hepatitis A, B or C",
"treatment": null
} | [
0,
0,
0,
2,
0,
0,
0,
2
] | [
"including",
"known",
"active",
"hepatitis",
"A,",
"B",
"or",
"C"
] | 3,347 |
NCT02851914 | 12:30:chronic_disease | History of psychotic disorder | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "psychotic disorder",
"treatment": null
} | [
0,
0,
2,
2
] | [
"History",
"of",
"psychotic",
"disorder"
] | 1,668 |
NCT03186872 | 35:44:chronic_disease | evidence of active suicidality or psychosis (brief screen conducted by SWer in clinic using DSM-V cross cutting symptom inventory) to assess for psychosis | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "psychosis",
"treatment": null
} | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"evidence",
"of",
"active",
"suicidality",
"or",
"psychosis",
"(brief",
"screen",
"conducted",
"by",
"SWer",
"in",
"clinic",
"using",
"DSM-V",
"cross",
"cutting",
"symptom",
"inventory)",
"to",
"assess",
"for",
"psychosis"
] | 1,603 |
NCT03116464 | 44:52:chronic_disease, | Be involved in the care of the person with dementia (at least 4 hours of care per day) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "dementia",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Be",
"involved",
"in",
"the",
"care",
"of",
"the",
"person",
"with",
"dementia",
"(at",
"least",
"4",
"hours",
"of",
"care",
"per",
"day)"
] | 1,315 |
NCT02805504 | 12:23:allergy_name | Allergy to bupivacaine | {
"allergy_name": "bupivacaine",
"cancer": null,
"chronic_disease": null,
"treatment": null
} | [
0,
0,
4
] | [
"Allergy",
"to",
"bupivacaine"
] | 3,924 |
NCT02566304 | 28:39:treatment,43:65:treatment,,88:98:treatment,131:140:treatment | Patients who have received alemtuzumab or antithymocyte globulin within 8 weeks of the transplant admission. The absence of these therapies in the medical record will serve as documentation that they were not given | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "therapies"
} | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Patients",
"who",
"have",
"received",
"alemtuzumab",
"or",
"antithymocyte",
"globulin",
"within",
"8",
"weeks",
"of",
"the",
"transplant",
"admission.",
"The",
"absence",
"of",
"these",
"therapies",
"in",
"the",
"medical",
"record",
"will",
"serve",
"as",
"docu... | 5,961 |
NCT02549833 | 34:51:chronic_disease | History or clinical suspicion of neurofibromatosis | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "neurofibromatosis",
"treatment": null
} | [
0,
0,
0,
0,
0,
2
] | [
"History",
"or",
"clinical",
"suspicion",
"of",
"neurofibromatosis"
] | 4,206 |
NCT02531932 | ,,63:72:treatment | Negative serum pregnancy test within 7 days prior to starting treatment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "treatment"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Negative",
"serum",
"pregnancy",
"test",
"within",
"7",
"days",
"prior",
"to",
"starting",
"treatment"
] | 988 |
NCT00862433 | 1:7:chronic_disease | Anemia | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Anemia",
"treatment": null
} | [
2
] | [
"Anemia"
] | 245 |
NCT02561988 | 1:7:cancer | SM-AHN | {
"allergy_name": null,
"cancer": "SM-AHN",
"chronic_disease": null,
"treatment": null
} | [
3
] | [
"SM-AHN"
] | 4,182 |
NCT01737502 | 1:18:cancer | carcinoma-in-situ of the cervix | {
"allergy_name": null,
"cancer": "carcinoma-in-situ",
"chronic_disease": null,
"treatment": null
} | [
3,
0,
0,
2
] | [
"carcinoma-in-situ",
"of",
"the",
"cervix"
] | 3,411 |
NCT02242110 | 1:24:chronic_disease | Intellectual disability | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "Intellectual disability",
"treatment": null
} | [
0,
0
] | [
"Intellectual",
"disability"
] | 3,215 |
NCT02541565 | ,,,149:159:treatment | Female subject of childbearing potential should have a negative urine or serum pregnancy within 72 hours prior to receiving the first dose of study medication | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "medication"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Female",
"subject",
"of",
"childbearing",
"potential",
"should",
"have",
"a",
"negative",
"urine",
"or",
"serum",
"pregnancy",
"within",
"72",
"hours",
"prior",
"to",
"receiving",
"the",
"first",
"dose",
"of",
"study",
"medication"
] | 621 |
NCT02502708 | 34:46:treatment,48:64:treatment,73:82:treatment | Patients previously treated with temozolomide, cyclophosphamide, and/or etoposide are eligible for enrollment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "etoposide"
} | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] | [
"Patients",
"previously",
"treated",
"with",
"temozolomide,",
"cyclophosphamide,",
"and/or",
"etoposide",
"are",
"eligible",
"for",
"enrollment"
] | 6,142 |
NCT01970176 | 1:13:chronic_disease,17:48:chronic_disease,50:57:chronic_disease,59:66:chronic_disease | Infiltrative or inflammatory myocardial disease (amyloid, sarcoid) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "sarcoid",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0
] | [
"Infiltrative",
"or",
"inflammatory",
"myocardial",
"disease",
"(amyloid,",
"sarcoid)"
] | 6,925 |
NCT01306045 | 15:43:cancer,27:43:cancer,110:119:chronic_disease,163:173:chronic_disease,163:185:chronic_disease,292:301:treatment,339:363:cancer,,428:443:treatment, | Patients with symptomatic brain metastases should be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events. However, patients who have had treatment for their brain met... | {
"allergy_name": null,
"cancer": "brain metastatic disease",
"chronic_disease": "neurologic dysfunction",
"treatment": "brain radiation"
} | [
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
3,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... | [
"Patients",
"with",
"symptomatic",
"brain",
"metastases",
"should",
"be",
"excluded",
"from",
"this",
"clinical",
"trial",
"because",
"of",
"their",
"poor",
"prognosis",
"and",
"because",
"they",
"often",
"develop",
"progressive",
"neurologic",
"dysfunction",
"that"... | 7,248 |
NCT01754298 | 1:13:treatment | chemotherapy treatment | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "chemotherapy"
} | [
1,
1
] | [
"chemotherapy",
"treatment"
] | 732 |
NCT02188745 | 7:18:chronic_disease, | Known CNS disease, unless clinically stable for ≥ 3 months | {
"allergy_name": null,
"cancer": null,
"chronic_disease": "CNS disease",
"treatment": null
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Known",
"CNS",
"disease,",
"unless",
"clinically",
"stable",
"for",
"≥",
"3",
"months"
] | 1,942 |
NCT02955394 | 1:38:treatment,40:51:treatment,53:60:treatment,62:74:treatment,76:88:treatment,90:97:treatment,99:106:treatment,108:115:treatment,117:124:treatment,126:132:treatment | Prior treatment with an anti-androgen (abiraterone, ARN-509, bicalutamide, enzalutamide, ODM-201, TAK-448, TAK-683, TAK-700, VT-464) | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "VT-464"
} | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] | [
"Prior",
"treatment",
"with",
"an",
"anti-androgen",
"(abiraterone,",
"ARN-509,",
"bicalutamide,",
"enzalutamide,",
"ODM-201,",
"TAK-448,",
"TAK-683,",
"TAK-700,",
"VT-464)"
] | 5,440 |
NCT02370693 | ,,,,58:71:treatment | Fall in FVC > 10% over 6 months on at least 12 months of prior therapy | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "prior therapy"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] | [
"Fall",
"in",
"FVC",
">",
"10%",
"over",
"6",
"months",
"on",
"at",
"least",
"12",
"months",
"of",
"prior",
"therapy"
] | 21 |
NCT02334579 | 23:46:cancer | Histologically proven prostate adenocarcinoma | {
"allergy_name": null,
"cancer": "prostate adenocarcinoma",
"chronic_disease": null,
"treatment": null
} | [
0,
0,
0,
3
] | [
"Histologically",
"proven",
"prostate",
"adenocarcinoma"
] | 2,103 |
NCT02815670 | 36:43:treatment,47:65:treatment,81:92:treatment | A condition requiring an emergency surgery or invasive procedure where adequate haemostasis | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "haemostasis"
} | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1
] | [
"A",
"condition",
"requiring",
"an",
"emergency",
"surgery",
"or",
"invasive",
"procedure",
"where",
"adequate",
"haemostasis"
] | 5,788 |
NCT02660528 | 21:59:treatment | having received the Bacillus Calmette-Guérin (BCG) vaccine | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "Bacillus Calmette-Guérin (BCG) vaccine"
} | [
0,
0,
0,
0,
0,
0,
4
] | [
"having",
"received",
"the",
"Bacillus",
"Calmette-Guérin",
"(BCG)",
"vaccine"
] | 4,038 |
NCT02073097 | 16:27:treatment,99:122:treatment,,,,,,,339:348:treatment,,,,,,,699:710:treatment | The effects of Carfilzomib on the developing human fetus are unknown. For this reason and because chemotherapeutic agents used in this study are known to be teratogenic, women of child-bearing potential and men must agree to use adequate contraception (double barrier method of birth control or abstinence) 2 weeks prior... | {
"allergy_name": null,
"cancer": null,
"chronic_disease": null,
"treatment": "carfilzomib"
} | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... | [
"The",
"effects",
"of",
"Carfilzomib",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown.",
"For",
"this",
"reason",
"and",
"because",
"chemotherapeutic",
"agents",
"used",
"in",
"this",
"study",
"are",
"known",
"to",
"be",
"teratogenic,",
"women",
... | 6,802 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.